Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuxing Hu

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 22, 2022
Tegaserod maleate exhibits antileukemic activity by targeting TRPM8Xiaoling Xie, Wanwen Yang, Wuju Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 27, 2023
Corrigendum to "Tegaserod maleate exhibits antileukemic activity by targeting TRPM8" [Biomed. Pharmacother. 154 (2022) 113566]Xiaoling Xie, Wanwen Yang, Wuju Zhang, et al.
Journal of Ethnopharmacology|July 25, 2023
Enhancing NKT cell-mediated immunity against hepatocellular carcinoma: Role of XYXD in promoting primary bile acid synthesis and improving gut microbiotaZhe Deng, Zhaoguang Ouyang, Si Mei, et al.
Nature Nanotechnology|October 26, 2021
Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effectsChanglong Wang, Wei Zhang, Yanjie He, et al.
Blood|March 31, 2023
TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in miceXiaoling Xie, Wuju Zhang, Min Xiao, et al.
Cell|March 10, 2026
Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemiasFeng Li, Yuxing Hu, Yan Wang, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 22, 2022
Tegaserod maleate exhibits antileukemic activity by targeting TRPM8Xiaoling Xie, Wanwen Yang, Wuju Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 27, 2023
Corrigendum to "Tegaserod maleate exhibits antileukemic activity by targeting TRPM8" [Biomed. Pharmacother. 154 (2022) 113566]Xiaoling Xie, Wanwen Yang, Wuju Zhang, et al.
Journal of Ethnopharmacology|July 25, 2023
Enhancing NKT cell-mediated immunity against hepatocellular carcinoma: Role of XYXD in promoting primary bile acid synthesis and improving gut microbiotaZhe Deng, Zhaoguang Ouyang, Si Mei, et al.
Nature Nanotechnology|October 26, 2021
Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effectsChanglong Wang, Wei Zhang, Yanjie He, et al.
Blood|March 31, 2023
TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in miceXiaoling Xie, Wuju Zhang, Min Xiao, et al.
Cell|March 10, 2026
Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemiasFeng Li, Yuxing Hu, Yan Wang, et al.
Pageof 5